Brief: Axovant Announces Amendment To Credit Facility With Hercules Capital
Dec 3 (Reuters) - Axovant Gene Therapies Ltd AXGT.O :
* AXOVANT ANNOUNCES AMENDMENT TO CREDIT FACILITY WITH
HERCULES
CAPITAL
* AXOVANT GENE THERAPIES - NEW LOAN AMENDMENT REDUCES LOAN
OBLIGATION BY 50% WITHOUT PENALTY, ELIMINATES MINIMUM CASH
COVENANT
* AXOVANT GENE THERAPIES - NEW LOAN AMENDMENT EXTENDS
INTEREST-ONLY PERIOD FOR 9 MONTHS
* AXOVANT GENE THERAPIES LTD - UNDER NEW LOAN AMENDMENT,
DEBT
SERVICE BURDEN REDUCED BY ABOUT $2.0 MILLION PER MONTH DURING
INTEREST-ONLY PERIOD
Source text for Eikon: ID:nGNX5w1qvX
Further company coverage: AXGT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sio Gene Therapies
See all newsBrief: Sio Gene Therapies Inc - On March 14, Got Notice That Nasdaq Has Determined That Company's Common Stock Will Be Delisted From Nasdaq Capital Market
Brief: Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial Results
Brief: Sio Gene Therapies Inc. Announces Board Approval Of Plan Of Complete Liquidation, Dissolution
Brief: Sio Gene Therapies Announces Second Quarter Financial Results
Brief: Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial Results